Philips Korea and HoneyNaps Sign Sleep and Cardiovascular Health MOU
Philips Korea, part of Royal Philips, and HoneyNaps signed a memorandum of understanding on August 19 to explore healthcare opportunities linking sleep disorders and cardiovascular health, the companies announced in a press release.
The partnership will focus on integrating sleep data with cardiovascular risk factors. The companies also plan to examine possible work in cardiology and other cardiovascular disease areas.
Philips Korea brings sleep and respiratory care products, healthcare provider networks, and commercial capabilities. HoneyNaps provides AI powered sleep medicine tools, including FDA authorized technology for sleep disorder diagnosis and analysis.
The companies said the collaboration may also include academic initiatives related to sleep and cardiovascular health.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Oct 16 BOC Group Adds AI Assistant to ADOIT 21 Oct 16 Huawei Brings Upgraded Stellar Network Solution to Europe Oct 16 Element to Manage Waymo's Toronto Fleet for 2028 Launch Oct 16 CTM and Huawei Plan AI Network Security Upgrades in Macao Oct 16 Huawei and 14 partners form Global AI CITY allianceMore from Life Sciences
Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice Operations Oct 15 Study Tracks 270 Million Clinical AI Queries on OpenEvidence Oct 15 OpenAI Offers US University Labs Free GPT-Rosalind AccessEnterprise AI Brief
Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Cambridge Heartwear Wins £184 Million NHS Tender for ECG Wearable
Flo Health Partners With Google Health on Wearables and Women's Health AI
Healthleap Raises $38 Million for Hospital Risk Screening AI
POMDOCTOR Outlines Predictive Healthcare Strategy
Helfie AI Plans Mobile Health Screening Pilot for 100,000 People in Kenya
Daily AI Brief: the AI news that matters, in your inbox.